Andrew Witty, UnitedHealth CEO, said the move will remove an excuse other players use to blame Optum Rx for high drug costs.

Says that while the company offers customers 100% pass-through options, “a small number have historically elected other models.” Witty says “We ...

House Energy Chair Brett Guthrie said he hopes to revive the health legislation that was pushed out of the American Relief ...

The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...

Mattingly is an associate professor and vice chair of research in the Department of Pharmacotherapy at the University of Utah ...

The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in ...

UnitedHealth Group reported $5.5 billion in profit for the fourth quarter of 2024, on par with its haul a year prior. | ...

A bipartisan, bicameral group of lawmakers is calling on the Federal Trade Commission (FTC) to vote in favor of releasing an ...

The pharmaceutical supply chain is a sector infamous for glacially slow adjustments, lackluster reform, lack of transparency ...

"While this information is theoretically available to the public, institutional owners' holdings are challenging to identify ...